Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis

NCT00929968 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: VAK694
DRUG: Fluticasone

Sponsor

Novartis Pharmaceuticals